NovelStem International Corp. (NSTM)
0.0066
0.00 (0.00%)
USD |
OTCM |
Oct 23, 16:00
NovelStem International Enterprise Value : 2.047M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.047M |
| October 22, 2026 | 2.047M |
| October 21, 2026 | 2.047M |
| October 20, 2026 | 2.190M |
| October 19, 2026 | 2.190M |
| October 16, 2026 | 2.190M |
| October 15, 2026 | 2.190M |
| October 14, 2026 | 2.190M |
| October 13, 2026 | 2.190M |
| October 12, 2026 | 2.190M |
| October 09, 2026 | 2.190M |
| October 08, 2026 | 2.190M |
| October 07, 2026 | 2.190M |
| October 06, 2026 | 2.190M |
| October 05, 2026 | 2.190M |
| October 02, 2026 | 2.190M |
| October 01, 2026 | 2.190M |
| September 30, 2026 | 2.190M |
| September 29, 2026 | 2.190M |
| September 28, 2026 | 2.190M |
| September 25, 2026 | 2.228M |
| September 24, 2026 | 2.228M |
| September 23, 2026 | 2.190M |
| September 22, 2026 | 2.190M |
| September 21, 2026 | 2.190M |
| Date | Value |
|---|---|
| September 18, 2026 | 2.190M |
| September 17, 2026 | 2.190M |
| September 16, 2026 | 2.358M |
| September 15, 2026 | 2.358M |
| September 14, 2026 | 2.190M |
| September 11, 2026 | 2.190M |
| September 10, 2026 | 2.190M |
| September 09, 2026 | 2.190M |
| September 08, 2026 | 2.190M |
| September 04, 2026 | 2.190M |
| September 03, 2026 | 2.190M |
| September 02, 2026 | 2.190M |
| September 01, 2026 | 2.190M |
| August 31, 2026 | 2.242M |
| August 28, 2026 | 2.190M |
| August 27, 2026 | 2.190M |
| August 26, 2026 | 2.190M |
| August 25, 2026 | 2.190M |
| August 24, 2026 | 2.190M |
| August 21, 2026 | 2.190M |
| August 20, 2026 | 2.028M |
| August 19, 2026 | 2.287M |
| August 18, 2026 | 2.287M |
| August 17, 2026 | 2.287M |
| August 14, 2026 | 2.287M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Brainstorm Cell Therapeutics, Inc. | 10.42M |
| Summit Therapeutics, Inc. | 11.60B |
| Kezar Life Sciences, Inc. | -11.12M |
| Protara Therapeutics, Inc. | -2.080M |
| Clene, Inc. | 62.25M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.0858M |
| Total Expenses (Quarterly) | 0.0858M |
| EPS Diluted (Quarterly) | -0.0017 |
| Earnings Yield | -96.97% |
| Normalized Earnings Yield | -98.48 |